Cargando…

Membrane-destabilizing ionizable phospholipids: Novel components for organ-selective mRNA delivery and CRISPR–Cas gene editing

Detalles Bibliográficos
Autores principales:	Meng, Ning, Grimm, Dirk
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Research Highlight
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8149719/ https://www.ncbi.nlm.nih.gov/pubmed/34035211 http://dx.doi.org/10.1038/s41392-021-00642-z

Ejemplares similares

Membrane destabilizing ionizable phospholipids for organ selective mRNA delivery and CRISPR/Cas gene editing
por: Liu, Shuai, et al.
Publicado: (2021)

The Cpf1 CRISPR-Cas protein expands genome-editing tools
por: Fagerlund, Robert D., et al.
Publicado: (2015)

Redefining mouse transgenesis with CRISPR/Cas9 genome editing technology
por: Burgio, Gaetan
Publicado: (2018)

CCR5-Δ32 biology, gene editing, and warnings for the future of CRISPR-Cas9 as a human and humane gene editing tool
por: Xu, MengMeng
Publicado: (2020)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
por: Kazemian, Pardis, et al.
Publicado: (2022)

Research highlights for issue 6: the CRISPR/Cas revolution
por: Koskella, Britt
Publicado: (2015)

CRISPR-mediated genome editing of Plasmodium falciparum malaria parasites
por: Lee, Marcus CS, et al.
Publicado: (2014)

On demand CRISPR-mediated RNA N6-methyladenosine editing
por: Xu, Ying, et al.
Publicado: (2022)

Advantages of using the CRISPR/Cas9 system of genome editing to investigate male reproductive mechanisms using mouse models
por: Young, Samantha AM, et al.
Publicado: (2015)

Selective ORgan Targeting (SORT) nanoparticles for tissue specific mRNA delivery and CRISPR/Cas gene editing
por: Cheng, Qiang, et al.
Publicado: (2020)

CRISPR-mediated RNA base editing: a promising strategy to rescue deafness
por: Liu, Wenyi, et al.
Publicado: (2023)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Editing base in mouse model
por: Wang, Haoyi
Publicado: (2017)

Strategies in the delivery of Cas9 ribonucleoprotein for CRISPR/Cas9 genome editing
por: Zhang, Song, et al.
Publicado: (2021)

Pop in, pop out: a novel gene-targeting strategy for use with CRISPR-Cas9
por: Kühn, Ralf, et al.
Publicado: (2015)

Nanovesicle-Mediated Delivery Systems for CRISPR/Cas Genome Editing
por: Kim, Dongyoon, et al.
Publicado: (2020)

CRISPR/Cas9 offers a new tool for studying the role of chromatin architecture in disease pathogenesis
por: Guo, Xiang, et al.
Publicado: (2018)

Membrane‐destabilizing ionizable lipid empowered imaging‐guided siRNA delivery and cancer treatment
por: Guo, Shuai, et al.
Publicado: (2021)

Protein stability regulators screening assay (Pro-SRSA): protein degradation meets the CRISPR–Cas9 library
por: Wu, Yuanzhong, et al.
Publicado: (2016)

Integrating gene delivery and gene-editing technologies by adenoviral vector transfer of optimized CRISPR-Cas9 components
por: Maggio, Ignazio, et al.
Publicado: (2020)

Genome editing enables defense-yield balance in rice
por: Deng, Yiwen, et al.
Publicado: (2023)

Nonviral gene editing via CRISPR/Cas9 delivery by membrane-disruptive and endosomolytic helical polypeptide
por: Wang, Hong-Xia, et al.
Publicado: (2018)

Linking phospholipid homeostasis with cardiac lipotoxicity in flies
Publicado: (2011)

Adenine base editing to mimic or correct disease mutations in rodents
por: Ren, Ruotong, et al.
Publicado: (2018)

Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing
por: Hashimoto, Masakazu, et al.
Publicado: (2015)

Skeletal Editing—Nitrogen Deletion of Secondary Amines by Anomeric Amide Reagents
por: Zippel, Christoph, et al.
Publicado: (2021)

CRISPR/Cas9 Delivery System Engineering for Genome Editing in Therapeutic Applications
por: Cheng, Hao, et al.
Publicado: (2021)

Recent advances in the delivery and applications of nonviral CRISPR/Cas9 gene editing
por: Sinclair, Frazer, et al.
Publicado: (2023)

Erratum: Electroporation enables the efficient mRNA delivery into the mouse zygotes and facilitates CRISPR/Cas9-based genome editing
por: Hashimoto, Masakazu, et al.
Publicado: (2015)

Adenovirus vector and mRNA vaccines: Mechanisms regulating their immunogenicity
por: Provine, Nicholas M., et al.
Publicado: (2022)

CRISPR sabotage
por: van der Oost, John, et al.
Publicado: (2015)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

Puzzling mRNA: Alternative splicing fine-tunes specificity and function
por: Häfner, Sophia Julia
Publicado: (2019)

Strategies for delivery of CRISPR/Cas-mediated genome editing to obtain edited plants directly without transgene integration
por: Kocsisova, Zuzana, et al.
Publicado: (2023)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
por: Zhang, Xiaoping, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_8f6fmlb21gtj0ren536430i1h4